A new analysis being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), finds that around half of the 100 top ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

This article was provided by Mary Washington Healthcare, a corporate sponsor of the Fredericksburg Free Press. As part of its ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Cancel anytime. Hugely popular weight loss drugs known as GLP-1's are finally getting cheaper, well at least one is, and that ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...